Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJNY.L Regulatory News (JNY)

  • There is currently no data for JNY

Form 8.3 - [Journey Group]

19 Oct 2016 09:53

RNS Number : 9391M
Close Asset Management Limited
19 October 2016
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Close Asset Management Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Journey Group Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

18/10/2016

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

25p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,397,905

11.8

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

1,397,905

11.8

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary Shares

Sale

10,550

234p

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

N/A

 

N/A

N/A

N/A

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

 

N/A

N/A

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

19/10/2016

Contact name:

Ciara Elliott

Telephone number:

020 7426 4124

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETGIBDGGUBBGLC
Date   Source Headline
28th Sep 20115:50 pmRNSTR1 Form
27th Sep 20117:00 amRNSInterim Results 2011
9th Sep 20113:22 pmRNSTR1 Form
9th Sep 20113:19 pmRNSTR1 Form
6th Sep 20113:14 pmRNSChange of Adviser
6th Sep 201112:25 pmRNSHolding(s) in Company
5th Sep 201111:15 amRNSContract Win
31st Aug 201111:41 amRNSExercise of Warrants
8th Jul 20117:00 amRNSDisposal
30th Jun 20117:00 amRNSTotal Voting Rights
20th Jun 201110:48 amRNSHolding(s) in Company
16th Jun 20112:52 pmRNSHolding(s) in Company
3rd Jun 20112:51 pmRNSDirector/PDMR Shareholding
23rd May 20117:00 amRNSNew Bank Facilities
18th May 20112:02 pmRNSChanges to the Board
1st Apr 20117:00 amRNSManagement Incentive Scheme
31st Mar 20117:00 amRNSFinal Results
16th Feb 20117:00 amRNSHolding(s) in Company
15th Feb 20113:36 pmRNSHolding(s) in Company
26th Jan 20119:40 amRNSTrading Statement
14th Dec 20108:54 amRNSChange of Adviser Name
3rd Dec 20101:54 pmRNSHolding(s) in Company
29th Nov 20107:00 amRNSDisposal
30th Sep 20107:00 amRNSHalf Yearly Report
3rd Sep 20102:30 pmRNSRefinancing
11th Jun 201011:11 amRNSHolding(s) in Company
11th Jun 201011:09 amRNSHolding(s) in Company
2nd Jun 20107:00 amRNSFinal Results
22nd Dec 20091:20 pmRNSBoard Appointments
8th Dec 20094:19 pmRNSDirector/PDMR Shareholding
8th Dec 20092:17 pmRNSHolding(s) in Company
23rd Nov 20093:06 pmRNSHolding(s) in Company
20th Nov 20093:52 pmRNSJoint Venture Agreement
30th Sep 20097:00 amRNSInterim Results
30th Jul 20097:00 amRNSJoint Venture Discussions
29th Jun 20097:00 amRNSAnnual Report & Accounts
16th Jun 20097:00 amRNSFinal Results
19th Feb 200911:08 amRNSDirectorate Change
9th Feb 200911:45 amRNSLAX Facility Update
2nd Feb 20094:38 pmRNSBoard Change
19th Jan 20099:00 amRNSDirectorate Change
7th Jan 20096:04 pmRNSDirector Declaration
29th Sep 20087:01 amRNSDirectorate Change
29th Sep 20087:00 amRNSInterim Results
8th Sep 20085:21 pmRNSHolding(s) in Company
4th Sep 20083:24 pmRNSHolding(s) in Company
4th Sep 200811:20 amRNSHolding(s) in Company
2nd Sep 20085:20 pmRNSHolding(s) in Company
2nd Sep 20085:17 pmRNSHolding(s) in Company
2nd Sep 20085:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.